Insulin sensitivity and blood pressure in a biethnic sample: The Miami Community Health Study

Journal of Clinical Epidemiology

Volumn 49, Issue 8, 1996, Pages 859-864

  Donahue, Richard P ^a   DeCarlo Donahue, Rosemary A ^b   Prineas, Ronald J ^a   Bean, Judy ^a   Gutt, Miriam ^a   Skyler, Jay S ^b   Schneiderman, Neil ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Department of Biology   (United States)

Author keywords

Blood pressure; Ethnicity; Insulin

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CAUCASIAN; DIASTOLIC BLOOD PRESSURE; ETHNIC GROUP; ETHNOLOGY; FEMALE; GLUCOSE TRANSPORT; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NEGRO; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; PUBLIC HEALTH; SYSTOLIC BLOOD PRESSURE; UNITED STATES;

EID: 0030220154     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-4356(96)00109-6     Document Type: Article

References (35)

1. 1. Modan M, Halkin H, Almong S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z. Hyperinsulinemia a link between hypertension obesity and glucose intolerance. J Clin Invest 1985; 75: 809-817.
2. 2. DeFronzo RA, Ferrannini E. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic heart disease. Diabetes Care 1992; 14: 173-194.
3. 3. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
4. 4. Donahue RP, Orchard RJ, Becker DJ, Kuller LH, Drash AK. Sex differences in the coronary heart disease risk factor profile: A possible role for insulin. Am J Epidemiol 1987; 125: 650-657.
5. 5. Williams RR, Hunt SC, Hopkins PN, et al. Familial dyslipidemic hypertension: Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. JAMA 1988; 259: 3579-3586.
6. 6. Skarfors ET, Lithell HO, Selinus I. Risk factors for the development of hypertension: A 10 year longitudinal study in middle-aged men. J Hypertension 1991; 9: 217-223.
7. 7. Cambien F, Warnet JM, Eschwege E, Jacqueson A, Richard JL, Rosselin G. Body mass, blood pressure, glucose, and lipids. Does plasma insulin explain their relationships? Arteriosclerosis 1987; 7: 197-202.
8. 8. Asch S, Wingard DL, Barrett-Connor EL. Are insulin and hypertension independently related? Ann Epidemiol 1991; 1: 231-244.
9. 9. Bonora E, Zavaroni I, Alpi O, Pezzarossa A, Bruschi F, Dall'Aglio E, Guerra L, Coscelli C, Butturini U. Relationship between blood pressure and plasma insulin in non-obese and obese non-diabetic subjects. Diabetologia 1987; 30: 719-723.
10. 10. Wing RR, Bunker CH, Kuller LH, Matthews KA. Insulin, body mass index, and cardiovascular risk factors in premenopausal women. Arteriosclerosis 1989; 9: 479-484.
11. 11. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH. Insulin and hypertension: Relationship to obesity and glucose intolerance in Pima Indians. Diabetes 1990; 39: 1430-1435.
12. 12. Collins VR, Dowse GK, Finch CF, Zimmett PZ. An inconsistent relationship between insulin and blood pressure in three Pacific island populations. J Clin Epidemiol 1990; 43: 1369-1378.
13. 13. Saad MF, Lillioja S, Nyomba BL, Castillo C, Rerraro R, DeGregorio M, Ravussin E, Knowler WC, Bennett PH, Howard BV, Bogardus C. Racial differences in the relation between blood pressure and insulin resistance. New Engl J Med 1991; 324: 733-739.
14. 14. Manolio RA, Savage PH, Burke GL, Liu K, Wagenknecht LE, Sidney S, Jacobs DR Jr, Roseman JM, Donahue RP, Oberman A. Association of fasting insulin with blood pressure and lipids in young adults. The CARDIA Study. Arteriosclerosis Thrombosis 1990; 10: 430-436.
15. 15. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 1993; 137: 959-965.
16. 16. Prineas RJ, Gillum RF, Horibe H, Hannan PJ. The Minneapolis Children's Blood Pressure Study. 1. Standards of measurement for children's blood pressure. Hypertension 1980; 2(Suppl. I): I18-I23.
17. 17. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-E223.
18. 18. Herbert V, Lau KS, Gottlieb CW. Coated charcoal immunoassay of insulin. J Clin Endocrinol 1965; 25: 1375-1384.
19. 19. SAS Institute, Inc. SAS User's Guide: Statistics, version 5. Cary, North Carolina: SAS Institute, Inc.; 1985.
20. 20. Ferrannini E, Bonadonna BR, Giorico MA, Oleggini M, Graziadeli L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-357.
21. 21. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992; 41: 715-722.
22. 22. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bunati PA, Bergonzani M, Gnudi L, Passeri M, Reaven G. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 1989; 320: 702-706.
23. 23. Falkner B, Hulman S, Kushner H. Insulin-stimulated glucose utilization and borderline hypertension in young adult blacks. Hypertension 1993; 22: 18-25.
24. 24. Manicardi V, Camellini L, Bellodi G, Coscelli C, Ferrannini E. Evidence for an association of high blood pressure and hyperinsulinemia in obese man. J Clin Endocr Metab 1986; 62: 1302-1304.
25. 25. Pollare T, Lithelt H. Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 1990; 39: 167-174.
26. 26. Istfan NW, Plaisted CS, Bistrian BR, Blackburn GL. Insulin resistance versus insulin secretion in the hypertension of obesity. Hypertension 1992; 19: 385-392.
27. 27. Rose G. Strategies of prevention. The individual and the population. In: Marmot M, Elliot P, Eds. Coronary Heart Disease Epidemiology. From Etiology to Public Health. Oxford, U.K.: Oxford University Press; 1992, pp. 311-324.
28. 28. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981; 30: 219-225.
29. 29. DeFronzo RA. The effect of insulin on renal sodium metabolism: A review with clinical implications. Diabetelogia 1981; 21: 165-171.
30. 30. Resnick LM, Gupta RK, Gruenspan H, Alderman MH, Laragh JH. Hypertension and peripheral insulin resistance. Possible mediating role of intracellular magnesium. Am J Hypertens 1990; 3: 373-379.
31. 31. Lipid Research Clinics Program. The Lipid Research Clinics Population Studies Data Book. Vol 1: The Prevalence Study. Bethesda, Maryland: National Institutes of Health; 1980.
32. 32. Donahue RP. The insulin resistance syndrome (syndrome X) and risk factors for coronary heart disease: An epidemiologic overview. Endocrinologist 1994; 4: 112-116.
33. 33. Rocchini AP, Katch V, Shork A, Kelch RP. Insulin and blood pressure during weight loss in obese adolescents. Hypertension 1987; 10: 262-273.
34. 34. Lohman D, Liebold F, Geilman W, et al. Diminished insulin response in highly trained athletes. Metabolism 1978; 27: 521-524.
35. 35. Krotkiewski M, Mandroukas K, Sjostrom L, et al. Effects of long-term physical training on body fat, metabolism, and blood pressure. Metabolism 1979; 28: 650-658.